Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed May 26, 2017
Insider Transaction Report
Form 4
FOURTEAU PATRICK
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-05-26−10,000→ 50,000 totalExercise: $3.63Exp: 2023-05-14→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2017-05-26$3.63/sh+10,000$36,300→ 59,682 total
Footnotes (1)
- [F1]The option was fully vested as of May 14, 2016.